SensiBile is developing a new biosensor (HepScan) to help assess the quality of donor livers prior-to-transplantation. Applied to discarded bile during organ retrieval, SensiBile HepScan determines the quality of the donor liver and its probability of developing complications post-operatively, allowing surgeons to make immediate informed decisions about the viability and further usage of the donor livers. SensiBile will help surgeons to predict transplantation viability, improving transplant success and long-term patient survival, which will have a corresponding impact on healthcare costs.